Renaissance Technologies (RenTech)'s HCAT Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 217,069 shares of Health Catalyst, Inc. (HCAT) worth $275,678, representing 0.00% of the portfolio. First purchased in 2021-Q1, this medium-term investment has been held for 18 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in HCAT, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 217,069 shares. Largest reduction occurred in Q2 2022, reducing 278,669 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Health Catalyst (HCAT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Health Catalyst (HCAT) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +217,069 | New Buy | 217,069 | $1.27 |
| Q4 2025 | -45,869 | Sold Out | 0 | $0.00 |
| Q3 2025 | +45,869 | New Buy | 45,869 | $2.85 |
| Q3 2024 | -14,700 | Sold Out | 0 | $0.00 |
| Q2 2024 | -52,200 | Reduce 78.03% | 14,700 | $6.39 |
| Q1 2024 | -32,369 | Reduce 32.61% | 66,900 | $7.53 |
| Q4 2023 | -60,200 | Reduce 37.75% | 99,269 | $9.26 |
| Q3 2023 | +4,869 | Add 3.15% | 159,469 | $10.12 |
| Q2 2023 | -112,469 | Reduce 42.11% | 154,600 | $0.01 |
| Q1 2023 | +78,707 | Add 41.78% | 267,069 | $0.01 |
| Q4 2022 | +31,489 | Add 20.07% | 188,362 | $0.01 |
| Q3 2022 | +98,473 | Add 168.62% | 156,873 | $9.70 |
| Q2 2022 | -278,669 | Reduce 82.67% | 58,400 | $14.49 |
| Q1 2022 | +57,700 | Add 20.65% | 337,069 | $26.13 |
| Q4 2021 | +79,300 | Add 39.64% | 279,369 | $39.62 |
| Q3 2021 | +52,000 | Add 35.12% | 200,069 | $50.01 |
| Q2 2021 | -9,408 | Reduce 5.97% | 148,069 | $55.51 |
| Q1 2021 | +157,477 | New Buy | 157,477 | $46.77 |
Renaissance Technologies (RenTech)'s Health Catalyst Investment FAQs
Renaissance Technologies (RenTech) first purchased Health Catalyst, Inc. (HCAT) in Q1 2021, acquiring 157,477 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Health Catalyst, Inc. (HCAT) for 18 quarters since Q1 2021.
Renaissance Technologies (RenTech)'s largest addition to Health Catalyst, Inc. (HCAT) was in Q1 2026, adding 217,069 shares worth $275,678.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 217,069 shares of Health Catalyst, Inc. (HCAT), valued at approximately $275,678.
As of the Q1 2026 filing, Health Catalyst, Inc. (HCAT) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Health Catalyst, Inc. (HCAT) was 337,069 shares, as reported at the end of Q1 2022.